A detailed history of Advisor Resource Council transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Advisor Resource Council holds 22,425 shares of LGND stock, worth $2.46 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
22,425
Holding current value
$2.46 Million
% of portfolio
0.18%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 21, 2025

BUY
$105.14 - $122.23 $2.36 Million - $2.74 Million
22,425 New
22,425 $2.36 Million
Q4 2023

Jan 12, 2024

BUY
$49.57 - $72.63 $138,994 - $203,654
2,804 New
2,804 $200,000

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.85B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Advisor Resource Council Portfolio

Follow Advisor Resource Council and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Resource Council, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Resource Council with notifications on news.